Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine
View ORCID ProfileMatan Levine-Tiefenbrun, View ORCID ProfileIdan Yelin, Hillel Alapi, Rachel Katz, Esma Herzel, Jacob Kuint, Gabriel Chodick, Sivan Gazit, Tal Patalon, View ORCID ProfileRoy Kishony
doi: https://doi.org/10.1101/2021.08.29.21262798
Matan Levine-Tiefenbrun
1Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel
2Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Idan Yelin
1Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel
Hillel Alapi
3Maccabitech, Maccabi Health Services, Tel Aviv, Israel
Rachel Katz
3Maccabitech, Maccabi Health Services, Tel Aviv, Israel
Esma Herzel
3Maccabitech, Maccabi Health Services, Tel Aviv, Israel
Jacob Kuint
2Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
3Maccabitech, Maccabi Health Services, Tel Aviv, Israel
Gabriel Chodick
2Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
3Maccabitech, Maccabi Health Services, Tel Aviv, Israel
Sivan Gazit
3Maccabitech, Maccabi Health Services, Tel Aviv, Israel
Tal Patalon
3Maccabitech, Maccabi Health Services, Tel Aviv, Israel
Roy Kishony
1Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel
4Faculty of Computer Science, Technion - Israel Institute of Technology, Haifa, Israel
Data Availability
According to the Israel Ministry of Health regulations, individual-level data cannot be shared openly. Specific requests for remote access to de-identified community-level data should be directed to KSM, Maccabi Healthcare Services Research and Innovation Center.
Posted September 01, 2021.
Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine
Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, Rachel Katz, Esma Herzel, Jacob Kuint, Gabriel Chodick, Sivan Gazit, Tal Patalon, Roy Kishony
medRxiv 2021.08.29.21262798; doi: https://doi.org/10.1101/2021.08.29.21262798
Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine
Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, Rachel Katz, Esma Herzel, Jacob Kuint, Gabriel Chodick, Sivan Gazit, Tal Patalon, Roy Kishony
medRxiv 2021.08.29.21262798; doi: https://doi.org/10.1101/2021.08.29.21262798
Subject Area
Subject Areas
- Addiction Medicine (379)
- Allergy and Immunology (694)
- Anesthesia (186)
- Cardiovascular Medicine (2806)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12492)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4360)
- Geriatric Medicine (397)
- Health Economics (710)
- Health Informatics (2805)
- Health Policy (1041)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (410)
- Medical Ethics (113)
- Nephrology (458)
- Neurology (4127)
- Nursing (219)
- Nutrition (612)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (315)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (478)
- Public and Global Health (6719)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)